Assessment of Regional Lung Ventilation Distribution During Supraglottic and Subglottic Jet Ventilation by EIT.
1 other identifier
interventional
30
1 country
1
Brief Summary
Objective: To estimate regional lung volume changes by electrical impedance tomography (EIT) during supra- and subglottic jet ventilation via the jet laryngoscope and LaserJet catheter for performing laryngotracheal surgery. Design: A monocentric, prospective, randomized study. Patients: Patients who require elective micro laryngo-tracheal surgery under jet ventilation. Interventions: Patients undergoing elective micro laryngeal surgery will be assigned to subglottic JV via the new LaserJet catheter and supraglottic JV via the jet laryngoscope vice versa. The sequence of JV modes will be randomized (subglottic followed by supraglottic or supraglottic followed by subglottic JV). Hemodynamic and ventilation parameters will be monitored. Arterial blood gas samples will be drawn and the regional ventilation distribution assessed, using the EIT. Outcomes measures: Reported EIT data of regional ventilation distribution, values of oxygenation and carbon dioxide elimination during the application of supra- and subglottic JV via jet laryngoscope and LaserJet catheter in patients undergoing laryngo-tracheal surgery. The purpose of this study is to investigate the influence of supraglottic and subglottic JV compared to standardized, controlled mask ventilation on measurements of pulmonary regional ventilation distribution by EIT, blood gas analyses and serological biomarkers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2019
CompletedFirst Posted
Study publicly available on registry
June 4, 2019
CompletedStudy Start
First participant enrolled
June 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 21, 2023
CompletedAugust 30, 2023
August 1, 2023
4.2 years
June 1, 2019
August 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Center of ventilation (COV)
Our primary aim is to determine whether supraglottic JV with the jet laryngoscope leads to a shift of the Center of Ventilation (COV) towards the ventral lungs compared to mask ventilation.
The EIT measurements will be recorded on arrival in the operating room (OR) under spontaneous breathing, during standardized, controlled mask ventilation and 5 minutes after supra- and subglottic JV.
Secondary Outcomes (5)
ROI 1-4
The EIT measurements will be recorded on arrival in the operating room (OR) under spontaneous breathing, during standardized, controlled mask ventilation and 5 minutes after supra- and subglottic JV.
ΔEELI
The EIT measurements will be recorded on arrival in the operating room (OR) under spontaneous breathing, during standardized, controlled mask ventilation and 5 minutes after supra- and subglottic JV.
silent spaces
The EIT measurements will be recorded on arrival in the operating room (OR) under spontaneous breathing, during standardized, controlled mask ventilation and 5 minutes after supra- and subglottic JV.
Blood gas analysis values
Blood will be drawn during mask ventilation, 5 minutes after supraglottic and 5 minutes after subglottic JV and at the end of surgery, before leaving to the recovery room for gas analysis and serum biomarkers.
Special serum biomarkers for pulmonary inflammation and parenchyma damage
Blood will be drawn during mask ventilation, 5 minutes after supraglottic and 5 minutes after subglottic JV and at the end of surgery, before leaving to the recovery room for gas analysis and serum biomarkers.
Study Arms (2)
Supraglottic jet ventilation
ACTIVE COMPARATORVentilation of the patient is performed over a steel laryngoscope or a thin catheter by means of jet ventilation (JV) using the TwinStream jet ventilator (C. Reiner Corp, Vienna, Austria). The driving pressure of the device is 1.5-3 bar and respiratory rates of 10-900 per min can be provided. In superimposed high frequency jet ventilation (SHFJV), jet ventilation of normal frequency and high frequency is conducted simultaneously and enables ventilation at two different pressure levels through the steel jet laryngoscope. It is equipped with two jet nozzles, which are placed at the distal end of the jet laryngoscope.
Subglottic jet ventilation
ACTIVE COMPARATORSubglottic HFJV is performed through the LaserJet catheter. It is characterized by the delivery of small tidal volumes from a high pressure jet at very high frequencies (100-400) followed by passive expiration for a very short period before delivering the next jet, creating an "auto-PEEP".
Interventions
The use of electrical impedance tomography (EIT) (SentecTom BB2, Landquart, Switzerland) allows the investigators to obtain a visual and quantitative representation of the areas of ventilation and aeration of the lung. The fundamental principle of lung EIT relies on the application of small alternating electrical currents into the thorax and voltage measurements using electrodes on the skin surface generating cross-sectional images representing impedance change in a slice of the thorax. It is a radiation-free imaging method which has the advantage to reveal real-time information. An array of electrodes (textile belt with 32 integrated electrocardiographic electrodes) has to be placed around the thorax to inject currents and to measure the resulting voltages on the thoracic surface.
Eligibility Criteria
You may qualify if:
- Patients undergoing elective micro-laryngotracheal surgery
- Ventilation type: SHFJV and HFJV
- Jet devices: Jet laryngoscope and LaserJet catheter
- ASA 1-3
- Age 18- 99 years.
You may not qualify if:
- acute bleeding in the area of the larynx/trachea
- infectious lung disease (e.g. tuberculosis)
- inability to perform retroflexion of the head (laryngoscope cannot be positioned properly)
- thoracic wall deformities
- obesity, BMI \>30kg/m2
- implantable electronic devices (f.e. pacemaker, ICD)
- emergency surgery
- expected postoperative mechanical ventilation (Intensive Care Unit)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University Vienna
Vienna, 1090, Austria
Related Publications (25)
Bacher A, Lang T, Weber J, Aloy A. Respiratory efficacy of subglottic low-frequency, subglottic combined-frequency, and supraglottic combined-frequency jet ventilation during microlaryngeal surgery. Anesth Analg. 2000 Dec;91(6):1506-12. doi: 10.1097/00000539-200012000-00039.
PMID: 11094009BACKGROUNDBacher A, Pichler K, Aloy A. Supraglottic combined frequency jet ventilation versus subglottic monofrequent jet ventilation in patients undergoing microlaryngeal surgery. Anesth Analg. 2000 Feb;90(2):460-5. doi: 10.1097/00000539-200002000-00041.
PMID: 10648340BACKGROUNDLanzenberger-Schragl E, Donner A, Grasl MC, Zimpfer M, Aloy A. Superimposed high-frequency jet ventilation for laryngeal and tracheal surgery. Arch Otolaryngol Head Neck Surg. 2000 Jan;126(1):40-4. doi: 10.1001/archotol.126.1.40.
PMID: 10628709BACKGROUNDRezaie-Majd A, Bigenzahn W, Denk DM, Burian M, Kornfehl J, Grasl MCh, Ihra G, Aloy A. Superimposed high-frequency jet ventilation (SHFJV) for endoscopic laryngotracheal surgery in more than 1500 patients. Br J Anaesth. 2006 May;96(5):650-9. doi: 10.1093/bja/ael074. Epub 2006 Mar 30.
PMID: 16574723BACKGROUNDDavies JM, Hillel AD, Maronian NC, Posner KL. The Hunsaker Mon-Jet tube with jet ventilation is effective for microlaryngeal surgery. Can J Anaesth. 2009 Apr;56(4):284-90. doi: 10.1007/s12630-009-9057-2. Epub 2009 Feb 25.
PMID: 19296189BACKGROUNDFrochaux D, Rajan GP, Biro P. [Laser-resistance of a new jet ventilation catheter (LaserJet) under simulated clinical conditions]. Anaesthesist. 2004 Sep;53(9):820-5. doi: 10.1007/s00101-004-0717-x. German.
PMID: 15448938BACKGROUNDFriedrich G, Mausser G, Gugatschka M. [Jet ventilation in laryngotracheal surgery]. HNO. 2008 Dec;56(12):1197-206. doi: 10.1007/s00106-008-1725-y. German.
PMID: 19020846BACKGROUNDWegrzynowicz ES, Jensen NF, Pearson KS, Wachtel RE, Scamman FL. Airway fire during jet ventilation for laser excision of vocal cord papillomata. Anesthesiology. 1992 Mar;76(3):468-9. doi: 10.1097/00000542-199203000-00022. No abstract available.
PMID: 1539860BACKGROUNDRubin JS, Patel A, Lennox P. Subglottic jet ventilation for suspension microlaryngoscopy. J Voice. 2005 Mar;19(1):146-50. doi: 10.1016/j.jvoice.2004.03.008.
PMID: 15766860BACKGROUNDHess MM, Fleischer S, Ernstberger M. New 445 nm blue laser for laryngeal surgery combines photoangiolytic and cutting properties. Eur Arch Otorhinolaryngol. 2018 Jun;275(6):1557-1567. doi: 10.1007/s00405-018-4974-8. Epub 2018 Apr 19.
PMID: 29675755BACKGROUNDHelmstaedter V, Tellkamp R, Schwab B, Lenarz T, Durisin M. [High-frequency jet ventilation in otorhinolaryngology - surgical and anaesthesiologic issues]. Laryngorhinootologie. 2014 Jul;93(7):455-60. doi: 10.1055/s-0034-1370925. Epub 2014 Mar 27. German.
PMID: 24676871BACKGROUNDJaquet Y, Monnier P, Van Melle G, Ravussin P, Spahn DR, Chollet-Rivier M. Complications of different ventilation strategies in endoscopic laryngeal surgery: a 10-year review. Anesthesiology. 2006 Jan;104(1):52-9. doi: 10.1097/00000542-200601000-00010.
PMID: 16394690BACKGROUNDHeinze H, Eichler W, Karsten J, Sedemund-Adib B, Heringlake M, Meier T. Functional residual capacity-guided alveolar recruitment strategy after endotracheal suctioning in cardiac surgery patients. Crit Care Med. 2011 May;39(5):1042-9. doi: 10.1097/CCM.0b013e31820eb736.
PMID: 21336125BACKGROUNDGreene KE, King TE Jr, Kuroki Y, Bucher-Bartelson B, Hunninghake GW, Newman LS, Nagae H, Mason RJ. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J. 2002 Mar;19(3):439-46. doi: 10.1183/09031936.02.00081102.
PMID: 11936520BACKGROUNDHaagsman HP, Hogenkamp A, van Eijk M, Veldhuizen EJ. Surfactant collectins and innate immunity. Neonatology. 2008;93(4):288-94. doi: 10.1159/000121454. Epub 2008 Jun 5.
PMID: 18525212BACKGROUNDWulf-Johansson H, Thinggaard M, Tan Q, Johansson SL, Schlosser A, Christensen K, Holmskov U, Sorensen GL. Circulating surfactant protein D is associated to mortality in elderly women: a twin study. Immunobiology. 2013 May;218(5):712-7. doi: 10.1016/j.imbio.2012.08.272. Epub 2012 Aug 20.
PMID: 22999473BACKGROUNDAihara K, Oga T, Harada Y, Chihara Y, Handa T, Tanizawa K, Watanabe K, Tsuboi T, Hitomi T, Mishima M, Chin K. Comparison of biomarkers of subclinical lung injury in obstructive sleep apnea. Respir Med. 2011 Jun;105(6):939-45. doi: 10.1016/j.rmed.2011.02.016. Epub 2011 Mar 12.
PMID: 21402472BACKGROUNDDetermann RM, Royakkers AA, Haitsma JJ, Zhang H, Slutsky AS, Ranieri VM, Schultz MJ. Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients. BMC Pulm Med. 2010 Feb 16;10:6. doi: 10.1186/1471-2466-10-6.
PMID: 20158912BACKGROUNDBroeckaert F, Clippe A, Knoops B, Hermans C, Bernard A. Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann N Y Acad Sci. 2000;923:68-77. doi: 10.1111/j.1749-6632.2000.tb05520.x.
PMID: 11193780BACKGROUNDSerpa Neto A, Campos PP, Hemmes SN, Bos LD, Bluth T, Ferner M, Guldner A, Hollmann MW, India I, Kiss T, Laufenberg-Feldmann R, Sprung J, Sulemanji D, Unzueta C, Melo MF, Weingarten TN, Boer AM, Pelosi P, Gama de Abreu M, Schultz MJ; PROVE Network Investigators. Kinetics of plasma biomarkers of inflammation and lung injury in surgical patients with or without postoperative pulmonary complications. Eur J Anaesthesiol. 2017 Apr;34(4):229-238. doi: 10.1097/EJA.0000000000000614.
PMID: 28187051BACKGROUNDHofbauer KH, Jensen BL, Kurtz A, Sandner P. Tissue hypoxygenation activates the adrenomedullin system in vivo. Am J Physiol Regul Integr Comp Physiol. 2000 Feb;278(2):R513-9. doi: 10.1152/ajpregu.2000.278.2.R513.
PMID: 10666155BACKGROUNDda Rosa DP, Forgiarini LF, Baronio D, Feijo CA, Martinez D, Marroni NP. Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver. Mediators Inflamm. 2012;2012:879419. doi: 10.1155/2012/879419. Epub 2012 Nov 26.
PMID: 23226929BACKGROUNDWrigge H, Uhlig U, Baumgarten G, Menzenbach J, Zinserling J, Ernst M, Dromann D, Welz A, Uhlig S, Putensen C. Mechanical ventilation strategies and inflammatory responses to cardiac surgery: a prospective randomized clinical trial. Intensive Care Med. 2005 Oct;31(10):1379-87. doi: 10.1007/s00134-005-2767-1. Epub 2005 Aug 17.
PMID: 16132888BACKGROUNDWrigge H, Uhlig U, Zinserling J, Behrends-Callsen E, Ottersbach G, Fischer M, Uhlig S, Putensen C. The effects of different ventilatory settings on pulmonary and systemic inflammatory responses during major surgery. Anesth Analg. 2004 Mar;98(3):775-81, table of contents. doi: 10.1213/01.ane.0000100663.11852.bf.
PMID: 14980936BACKGROUNDZhang X, Xie M, Gao Y, Wei HH, Zheng JQ. [Study on the effect and mechanism of hypoxia on the histological structure of rat's lung]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 Jan;43(1):1-5. Chinese.
PMID: 22455120BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Marita Windpassinger, MD, MBA
Medical University of Vienna
- STUDY DIRECTOR
Olga Plattner, MD
Medical University of Vienna
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 1, 2019
First Posted
June 4, 2019
Study Start
June 7, 2019
Primary Completion
August 21, 2023
Study Completion
August 21, 2023
Last Updated
August 30, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share